Report

Kinarus Therapeutics - Antiviral activity against Omicron BA.2/BA.5

Kinarus has reported that its preclinical data on lead candidate KIN001 have shown strong antiviral efficacy against SARS-CoV-2 Omicron subvariants BA.2 and BA.5, which account for about a quarter of US COVID-19 infections. This builds on previously reported in vitro data, indicative of robust antiviral efficacy of equal potency against the original SARS-CoV-2 strain and other variants of concern, including Delta. We view this development as continued validation of KIN001’s mechanism of action involving antiviral, anti-inflammatory and anti-fibrotic activity, as well as its ‘variant-agnostic’ level of activity against SARS-CoV-2. We highlight that other SARS-CoV-2 variants are emerging, including the Omicron BQ subvariants, and KIN001’s effectiveness to date against multiple variants suggests it may also maintain potency against BQ and other future (sub)variants as well.
Underlying
Perfect Holding S.A.

Perfect Holding SA. Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The Company operates under four business divisions: optical disc, aircraft management, charters and brokerage. Perfect Holding SA, through its subsidiaries, is dedicated to the provision of services to the business aircraft market such as aircraft management, aircraft sales, charter sales and travel services. The Company manages medium- to large-business aircrafts, such as Bombardier Global and Challenger jets. The Company wholly owns three subsidiaries, including Perfect Aviation SA, based in Switzerland, Perfect Aviation Portugal SA, based in Portugal and Perfect Aviation UK Ltd, based in the United Kingdom.

Provider
Edison Investment Research
Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

.

Analysts
Sean Conroy

Other Reports on these Companies
Other Reports from Edison Investment Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch